Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics

Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; De Clercq Erik; Marc Van Ranst; Svetlana S. Printsevskaya; Eugenia N. Olsufyeva; Svetlana E. Solovieva; M. N. Preobrazhenskaya

doi:10.1016/j.antiviral.2006.03.005

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Antiretroviral Activity of Semisynthetic Derivatives of Glycopeptide Antibiotics

Jan Balzarini, Christophe Pannecouque, De Clercq Erik, Andrey Y. Pavlov, Svetlana S. Printsevskaya, О. В. Мирошникова, Marina I. Reznikova, M. N. Preobrazhenskaya

Article2005

Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture

Jan Balzarini, Els Keyaerts, Leen Vijgen, Frank Vandermeer, Miguel Stevens, De Clercq Erik, Herman Egberink, Marc Van Ranst

Article2003

Derivatives of glycopeptide antibiotics with anti-retroviral activities

M. N. Preobrazhenskaya, S. S. Printsevskaya, A. Y. PAVLOV, Christophe Pannecouque, De Clercq Erik, Jan Balzarini

Article2004

Inhibitory activity of vancomycin, eremomycin and teicoplanin aglycon derivatives against feline and human coronaviruses (i.e. SARS)

Jan Balzarini, Els Keyaerts, Leen Vijgen, De Clercq Erik, M. N. Preobrazhenskaya, Marc Van Ranst

Article1996

Crystal structures of vancomycin-related glycopeptide antibiotics

Martina Schaefer, Tatjana Schneider, In Memory: G.M. Sheldrick (1942–2025)

Acta Crystallographica Section A Foundations of Crystallography